Literature DB >> 1921985

2'-Deoxy-6-thioguanosine 5'-triphosphate as a substrate for purified human DNA polymerases and calf thymus terminal deoxynucleotidyltransferase in vitro.

Y H Ling1, J A Nelson, Y C Cheng, R S Anderson, K L Beattie.   

Abstract

2'-Deoxy-6-thioguanosine 5'-triphosphate (S6dGTP), a metabolite of the antileukemia agent 6-thioguanine, was evaluated as a substrate for purified human DNA polymerases. Using bacteriophage M13 single-strand DNA as a template, S6dGTP substituted efficiently for dGTP and stimulated DNA synthesis in reactions without dGTP, with DNA polymerases alpha, delta, and gamma from the human leukemia cell line K562. The apparent Km values for dGTP and S6dGTP were very similar, i.e., 1.2 microM each for polymerase alpha, 2.8 and 3.6 microM, respectively, for polymerase delta, and 0.8 microM each for polymerase gamma; however, the relative Vmax values for the modified nucleotide were 25-50% lower than those of the corresponding natural substrate. Using a highly sensitive electrophoretic assay of chain elongation across M13mp9 (+)-strand DNA by the aforementioned human DNA polymerases, S6dGTP was shown to be incorporated at the 3' end of the nascent growing DNA chain, and the patterns of chain extension with S6dGTP as substrate were identical to those obtained in the presence of dGTP. There were no major differences using S6dGTP in place of dGTP with these DNA polymerases; however, at higher concentrations (1-10 microM) the analog stimulated primer elongation in reactions without dATP, indicating some misincorporation at sites of S6G.T base pairs during DNA synthesis. Using p(dA)12-18 as the initiator for calf thymus terminal deoxynucleotidyltransferase, S6dGTP inhibited the incorporation of all four natural deoxyribonucleoside 5'-triphosphates into the primer, in a competitive manner. The apparent Ki values for the analog were 6-20 times lower than the Km values for the four endogenous substrates. As a substrate, S6dGTP was added to the 3'-hydroxyl termini of primer, although tailing efficiency with the analog was lower than that in the presence of the natural substrate. These findings indicate that S6dGTP is a relatively good substrate for several mammalian DNA polymerases, including terminal deoxynucleotidyltransferase.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1921985

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  12 in total

1.  NUDT15 Hydrolyzes 6-Thio-DeoxyGTP to Mediate the Anticancer Efficacy of 6-Thioguanine.

Authors:  Nicholas C K Valerie; Anna Hagenkort; Brent D G Page; Geoffrey Masuyer; Daniel Rehling; Megan Carter; Luka Bevc; Patrick Herr; Evert Homan; Nina G Sheppard; Pål Stenmark; Ann-Sofie Jemth; Thomas Helleday
Journal:  Cancer Res       Date:  2016-08-16       Impact factor: 12.701

2.  Enhanced base pairing and replication efficiency of thiothymidines, expanded-size variants of thymidine.

Authors:  Herman O Sintim; Eric T Kool
Journal:  J Am Chem Soc       Date:  2006-01-18       Impact factor: 15.419

3.  Elevated Mutational Age in Blood of Children Treated for Cancer Contributes to Therapy-Related Myeloid Neoplasms.

Authors:  Eline J M Bertrums; Axel K M Rosendahl Huber; Jurrian K de Kanter; Arianne M Brandsma; Anaïs J C N van Leeuwen; Mark Verheul; Marry M van den Heuvel-Eibrink; Rurika Oka; Markus J van Roosmalen; Hester A de Groot-Kruseman; C Michel Zwaan; Bianca F Goemans; Ruben van Boxtel
Journal:  Cancer Discov       Date:  2022-08-05       Impact factor: 38.272

4.  Structures of a DNA Polymerase Inserting Therapeutic Nucleotide Analogues.

Authors:  Matthew A Schaich; Mallory R Smith; Ashley S Cloud; Sean M Holloran; Bret D Freudenthal
Journal:  Chem Res Toxicol       Date:  2017-09-01       Impact factor: 3.739

5.  Massively parallel variant characterization identifies NUDT15 alleles associated with thiopurine toxicity.

Authors:  Chase C Suiter; Takaya Moriyama; Kenneth A Matreyek; Wentao Yang; Emma Rose Scaletti; Rina Nishii; Wenjian Yang; Keito Hoshitsuki; Minu Singh; Amita Trehan; Chris Parish; Colton Smith; Lie Li; Deepa Bhojwani; Liz Y P Yuen; Chi-Kong Li; Chak-Ho Li; Yung-Li Yang; Gareth J Walker; James R Goodhand; Nicholas A Kennedy; Federico Antillon Klussmann; Smita Bhatia; Mary V Relling; Motohiro Kato; Hiroki Hori; Prateek Bhatia; Tariq Ahmad; Allen E J Yeoh; Pål Stenmark; Douglas M Fowler; Jun J Yang
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-24       Impact factor: 11.205

Review 6.  Enzymology of purine and pyrimidine antimetabolites used in the treatment of cancer.

Authors:  William B Parker
Journal:  Chem Rev       Date:  2009-07       Impact factor: 60.622

7.  How DNA damage and non-canonical nucleotides alter the telomerase catalytic cycle.

Authors:  Samantha L Sanford; Griffin A Welfer; Bret D Freudenthal; Patricia L Opresko
Journal:  DNA Repair (Amst)       Date:  2021-07-31

8.  Properties of pseudo-complementary DNA substituted with weakly pairing analogs of guanine or cytosine.

Authors:  Georges Lahoud; Victor Timoshchuk; Alexandre Lebedev; Khalil Arar; Ya-Ming Hou; Howard Gamper
Journal:  Nucleic Acids Res       Date:  2008-11-05       Impact factor: 16.971

9.  Effects of NT5C2 Germline Variants on 6-Mecaptopurine Metabolism in Children With Acute Lymphoblastic Leukemia.

Authors:  Chuang Jiang; Wenjian Yang; Takaya Moriyama; Chengcheng Liu; Colton Smith; Wentao Yang; Maoxiang Qian; Ziping Li; Morten Tulstrup; Kjeld Schmiegelow; Kristine R Crews; Hui Zhang; Ching-Hon Pui; William Evans; Mary Relling; Smita Bhatia; Jun J Yang
Journal:  Clin Pharmacol Ther       Date:  2020-11-24       Impact factor: 6.903

Review 10.  Nucleobase and Nucleoside Analogues: Resistance and Re-Sensitisation at the Level of Pharmacokinetics, Pharmacodynamics and Metabolism.

Authors:  Nikolaos Tsesmetzis; Cynthia B J Paulin; Sean G Rudd; Nikolas Herold
Journal:  Cancers (Basel)       Date:  2018-07-23       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.